Methylphenidate Raclopride Positron Emission Tomography (PET) Test - 11
Phase 4
Completed
- Conditions
- Substance-Related DisordersCocaine-Related Disorders
- First Posted Date
- 2001-04-18
- Last Posted Date
- 2017-02-24
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00015301
- Locations
- ๐บ๐ธ
New York MDRU, New York, New York, United States
Pathophysiological Subtyping of Abnormalities in Cocaine Dependence - 9
Phase 4
Completed
- Conditions
- Substance-Related DisordersCocaine-Related Disorders
- First Posted Date
- 2001-04-18
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00015275
- Locations
- ๐บ๐ธ
New York MDRU, New York, New York, United States
Buprenorphine and Naloxone Combination Study - 10
Phase 1
Completed
- Conditions
- Heroin DependenceOpioid-Related Disorders
- First Posted Date
- 2001-04-18
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00015288
- Locations
- ๐บ๐ธ
New York MDRU, New York, New York, United States
Randomized Study of Interventions to Enhance Adherence to Isoniazid Prevention Therapy for Tuberculosis in Injection Drug Users
Not Applicable
- Conditions
- Tuberculosis
- First Posted Date
- 2000-02-25
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 300
- Registration Number
- NCT00004740
Phase II Double-Blind, Placebo-Controlled Study of the Reinforcing Effects of Alprazolam in Patients With Anxiety
Phase 2
Completed
- Conditions
- Anxiety DisorderPanic Disorder
- First Posted Date
- 1999-10-19
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 80
- Registration Number
- NCT00004373
- Locations
- ๐บ๐ธ
University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States
Pharmacotherapy and Intensive Treatment - 2
Phase 4
Completed
- Conditions
- Cocaine-Related DisordersSubstance-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 353
- Registration Number
- NCT00000218
- Locations
- ๐บ๐ธ
University of Kansas, Kansas City, Missouri, United States
Buprenorphine Detoxification With Two Types of Treatment. BBD IV - 13
Phase 2
Completed
- Conditions
- Opioid-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2005-08-17
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000231
- Locations
- ๐บ๐ธ
Treatment Research Center, Burlington, Vermont, United States
Progesterone Treatment in Female Smokers - 12
Phase 2
Completed
- Conditions
- Tobacco Use Disorder
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000295
- Locations
- ๐บ๐ธ
University of Minnesota, Minneapolis, Minnesota, United States
Cocaine Effects in Humans: Physiology and Behavior - 1
Phase 2
Completed
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 19
- Registration Number
- NCT00000200
- Locations
- ๐บ๐ธ
Columbia University, New York, New York, United States
Effects of Carvedilol on Cocaine Use in Humans - 11
Phase 2
Completed
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000294
- Locations
- ๐บ๐ธ
University of Minnesota, Minneapolis, Minnesota, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath